Biotech ven­ture cham­pi­on Bill Maris is ex­it­ing GV. What’s next?

In the biotech start­up world, GV (the ven­ture group still usu­al­ly re­ferred to by its orig­i­nal name, Google Ven­tures) is the ide­al in­vestor. They bring leg­endary con­nec­tions, seem­ing­ly end­less cash re­sources and the kind of tech en­dorse­ment that can leave you smil­ing in your sleep. And now the cham­pi­on of life sci­ences in­vest­ing at GV, Bill Maris, is step­ping away from the helm af­ter found­ing it 8 years ago.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.